Zoetis Inc. Restructuring Charges
Zoetis Inc. (ZTS) reported Restructuring Charges of $95.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-08-06
- Zoetis Inc. restructuring charges for the quarter ending 2026-06-30 was $75.00M.
- Zoetis Inc. restructuring charges for the quarter ending 2026-03-31 was $20.00M.
- Zoetis Inc. restructuring charges for the quarter ending 2025-12-31 was $16.00M.
- Zoetis Inc. restructuring charges for the quarter ending 2025-09-30 was $4.00M.
- Zoetis Inc. restructuring charges for fiscal 2025 was $49.00M, a 13.95% increase from fiscal 2024.
- Zoetis Inc. restructuring charges for fiscal 2024 was $43.00M, a 6.52% decline from fiscal 2023.
- Zoetis Inc. restructuring charges for fiscal 2023 was $46.00M, a 666.67% increase from fiscal 2022.
- Zoetis Inc. restructuring charges for fiscal 2022 was $6.00M, a 81.82% decline from fiscal 2021.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2026-06-30 | $75.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $95.00M 10-Q · filed 2026-08-06 | $111.00M derived: sum of 3 quarters · filed 2026-08-06 | $115.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $20.00M 10-Q · filed 2026-05-07 | $36.00M derived: sum of 2 quarters · filed 2026-05-07 | $40.00M derived: sum of 3 quarters · filed 2026-05-07 | |
| 2025-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $20.00M derived: sum of 2 quarters · filed 2026-02-12 | $49.00M 10-K · filed 2026-02-12 | |
| 2025-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $33.00M 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $29.00M 10-Q · filed 2025-08-05 | |||
| 2024-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$5.00M derived: sum of 2 quarters · filed 2026-02-12 | $32.00M derived: sum of 3 quarters · filed 2026-02-12 | $43.00M 10-K · filed 2026-02-12 |
| 2024-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $35.00M derived: sum of 2 quarters · filed 2024-11-04 | $46.00M 10-Q · filed 2024-11-04 | $54.00M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $37.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $48.00M 10-Q · filed 2024-08-06 | $56.00M derived: sum of 3 quarters · filed 2026-02-12 | $69.00M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $11.00M 10-Q · filed 2024-05-02 | $19.00M derived: sum of 2 quarters · filed 2026-02-12 | $32.00M derived: sum of 3 quarters · filed 2026-02-12 | $37.00M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $21.00M derived: sum of 2 quarters · filed 2026-02-12 | $26.00M derived: sum of 3 quarters · filed 2026-02-12 | $46.00M 10-K · filed 2026-02-12 |
| 2023-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $18.00M derived: sum of 2 quarters · filed 2023-11-02 | $38.00M 10-Q · filed 2023-11-02 | $39.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $25.00M 10-Q · filed 2023-08-08 | $26.00M derived: sum of 3 quarters · filed 2025-02-13 | |
| 2023-03-31 | $20.00M 10-Q · filed 2023-05-04 | $21.00M derived: sum of 2 quarters · filed 2025-02-13 | ||
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $6.00M 10-K · filed 2025-02-13 | ||
| 2022-09-30 | $5.00M 10-Q · filed 2022-11-03 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $8.00M derived: sum of 2 quarters · filed 2024-02-13 | $27.00M derived: sum of 3 quarters · filed 2024-02-13 | $33.00M 10-K · filed 2024-02-13 |
| 2021-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $27.00M derived: sum of 2 quarters · filed 2021-11-04 | $33.00M 10-Q · filed 2021-11-04 | $34.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $25.00M 10-Q · filed 2021-08-05 | $26.00M derived: sum of 3 quarters · filed 2023-02-14 | $28.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $6.00M 10-Q · filed 2021-05-06 | $7.00M derived: sum of 2 quarters · filed 2023-02-14 | $9.00M derived: sum of 3 quarters · filed 2023-02-14 | $11.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $3.00M derived: sum of 2 quarters · filed 2023-02-14 | $5.00M derived: sum of 3 quarters · filed 2023-02-14 | $8.00M 10-K · filed 2023-02-14 |
| 2020-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.00M derived: sum of 2 quarters · filed 2020-11-05 | $7.00M 10-Q · filed 2020-11-05 | $20.00M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $5.00M 10-Q · filed 2020-08-06 | $18.00M derived: sum of 3 quarters · filed 2022-02-15 | $20.00M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $3.00M 10-Q · filed 2020-05-06 | $16.00M derived: sum of 2 quarters · filed 2022-02-15 | $18.00M derived: sum of 3 quarters · filed 2022-02-15 | $32.00M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $15.00M derived: sum of 2 quarters · filed 2022-02-15 | $29.00M derived: sum of 3 quarters · filed 2022-02-15 | $33.00M 10-K · filed 2022-02-15 |
| 2019-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $16.00M derived: sum of 2 quarters · filed 2019-11-07 | $20.00M 10-Q · filed 2019-11-07 | $23.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $14.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $18.00M 10-Q · filed 2019-08-06 | $21.00M derived: sum of 3 quarters · filed 2021-02-16 | $38.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $4.00M 10-Q · filed 2019-05-02 | $7.00M derived: sum of 2 quarters · filed 2021-02-16 | $24.00M derived: sum of 3 quarters · filed 2021-02-16 | $29.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $20.00M derived: sum of 2 quarters · filed 2021-02-16 | $25.00M derived: sum of 3 quarters · filed 2021-02-16 | $26.00M 10-K · filed 2021-02-16 |
| 2018-09-30 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $22.00M derived: sum of 2 quarters · filed 2018-11-01 | $23.00M 10-Q · filed 2018-11-01 | $33.00M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $6.00M 10-Q · filed 2018-08-02 | $16.00M derived: sum of 3 quarters · filed 2020-02-13 | $22.00M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $1.00M 10-Q · filed 2018-05-02 | $11.00M derived: sum of 2 quarters · filed 2020-02-13 | $17.00M derived: sum of 3 quarters · filed 2020-02-13 | $15.00M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $16.00M derived: sum of 2 quarters · filed 2020-02-13 | $14.00M derived: sum of 3 quarters · filed 2020-02-13 | $13.00M 10-K · filed 2020-02-13 |
| 2017-10-01 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $4.00M derived: sum of 2 quarters · filed 2017-11-02 | $3.00M 10-Q · filed 2017-11-02 | $22.00M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-07-02 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$3.00M 10-Q · filed 2017-08-08 | $16.00M derived: sum of 3 quarters · filed 2019-02-14 | $20.00M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-04-02 | -$1.00M 10-Q · filed 2017-05-04 | $18.00M derived: sum of 2 quarters · filed 2019-02-14 | $22.00M derived: sum of 3 quarters · filed 2019-02-14 | -$1.00M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $23.00M derived: sum of 2 quarters · filed 2019-02-14 | $0.00 derived: sum of 3 quarters · filed 2019-02-14 | $2.00M 10-K · filed 2019-02-14 |
| 2016-10-02 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$19.00M derived: sum of 2 quarters · filed 2016-11-03 | -$17.00M 10-Q · filed 2016-11-03 | $13.00M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-07-03 | -$23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$21.00M 10-Q · filed 2016-08-05 | $9.00M derived: sum of 3 quarters · filed 2018-02-15 | $17.00M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-04-03 | $2.00M 10-Q · filed 2016-05-06 | $32.00M derived: sum of 2 quarters · filed 2018-02-15 | $40.00M derived: sum of 3 quarters · filed 2018-02-15 | $303.00M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $30.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $38.00M derived: sum of 2 quarters · filed 2018-02-15 | $301.00M derived: sum of 3 quarters · filed 2018-02-15 | $301.00M 10-K · filed 2018-02-15 |
| 2015-09-27 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $271.00M derived: sum of 2 quarters · filed 2015-11-05 | $271.00M 10-Q · filed 2015-11-05 | $283.00M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-28 | $263.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $263.00M 10-Q · filed 2015-08-06 | $275.00M derived: sum of 3 quarters · filed 2017-02-16 | $276.00M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-29 | $0.00 10-Q · filed 2015-05-07 | $12.00M derived: sum of 2 quarters · filed 2017-02-16 | $13.00M derived: sum of 3 quarters · filed 2017-02-16 | $16.00M derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $13.00M derived: sum of 2 quarters · filed 2017-02-16 | $16.00M derived: sum of 3 quarters · filed 2017-02-16 | $17.00M 10-K · filed 2017-02-16 |
| 2014-09-28 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $4.00M derived: sum of 2 quarters · filed 2014-11-10 | $5.00M 10-Q · filed 2014-11-10 | $36.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-29 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $4.00M 10-Q · filed 2014-08-12 | $35.00M derived: sum of 3 quarters · filed 2016-02-24 | $36.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-30 | $1.00M 10-Q · filed 2014-05-13 | $32.00M derived: sum of 2 quarters · filed 2016-02-24 | $33.00M derived: sum of 3 quarters · filed 2016-02-24 | $3.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $32.00M derived: sum of 2 quarters · filed 2016-02-24 | $2.00M derived: sum of 3 quarters · filed 2016-02-24 | $5.00M 10-K · filed 2016-02-24 |
| 2013-09-29 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$29.00M derived: sum of 2 quarters · filed 2013-11-13 | -$26.00M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | -$30.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$27.00M 10-Q · filed 2013-08-14 | ||
| 2013-03-31 | $3.00M 10-Q · filed 2013-05-15 | |||
| 2012-12-31 | $52.00M 10-K · filed 2015-02-27 | |||
| 2012-04-01 | $24.00M 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |